The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Bubs To my knowledge no company has ever given a treatment for any medical condition via the chewing gum route.The wise woman would ask herself why? The unwise would be 100 per cent certain they are correct.
Cliostock
With respect but your post stirs up the negativity in me.Ijust dont get the chewing gum thing although I am ancient and do not have a degree in marketing.Teenagers use chewing gum and teenagers get acne so lets put the bacteria in chewing gum!! Seems a bit simplistic yet paradoxically it adds in a multitude of complications.I assume the consumer study did not use chewing gum as the supply vector so if the study was done with sachets then we have to go again to make any efficacy claims.What price would this chewing gum be? Would we get enough bacteria in chewing gum to achieve efficacy, do the bacteria need to survive mastication and salivary enzymes?
Teenagers will have no problem recognising acne as a medical condition and understand that you need a medicine to treat it and already have an understanding that certain illnesses require regular treatment such as sachets.Who associates chewing gum with treatment of a medical condition?..correct nobody other than trendy 'influencers' who know little about the real world.
I am not sure that investors understand just what a gift from heaven an effective probiotic product is.Its a beautiful thing that it doesn't cure anybody..that would be commercial disaster.Its a high margin product that significantly helps psoriasis and hopefully acne. but as soon as the customer stops the treatment the condition returns!As a product it could not be better.Just think of the acne market that we can tap into with the right marketing...Teenagers and indeed others can get significant help for this socially negative disease and take the product everyday for years, ditto psoriasis and possibly a group of immune related conditions eg hay fever,skin allergies and so on and so on.
Markets usually show a gamble on the future and there is no way that the bets are already placed here but they will be when positive news comes in.Some punters still see our products as snake oils but they are very very wrong.
There is obviously some confusion re the Acne Study the results of which will be released very very soon.This is the consumer study and not a study prior to a consumer study.The results will obviously be very positive as strongly indicated by SA in the TW interview.
I am a strong believer in the psoriasis product but I would like to see a bit more clarity re efficacy results.At present we have a hotchpotch of users on review sites using it for a variety of conditions and this clouds the answers re efficacy.Surely a simple clinical study could be done by identifying users who have had a doctor/nurse diagnosis of psoriasis.A number say 50 maybe less could then be randomly targeted with a short questionnaire to find out their subjective opinions re efficacy of the product eg After using this product for more than 10 weeks can you see visual improvement in your psoriasis rash?
A positive result via this sort of study would give the company a strong hand both in selling the product and in discussions re the product.It would remove the blurring that is present without such information.
I am fully aware of the Bright study but to the more expert eye there are a number of limitations in this study although it is certainly of interest.
I hope the soon to be released Acne Study gives us clarity in the results and in the discussion of the same.
Psoriasis is a very difficult condition to treat and to get high levels of patient satisfaction would be nothing short of astonishing.If we can produce unambiguous results this would surely put a rocket under discussions.
Topped up after seeing the interview.Stuart is extremely bullish in a calm and professional way.Nod nod wink wink the Acne results will be out within 2 months and the results will be positive. You can trust me on that one!
Are the acne results in the share price already?..I have no idea but clearly we will get an SP rise when they are released [very soon wink wink!!]
I am a buyer and my optimism has returned
There is no point doing business with the NHS because probiotics are on a blacklist of 'treatments of unproven value' and so cannot be prescribed.The Hull Trial is covered by a private research grant...BHF I think it is without looking it up.
Continuing my rekindled love affair with Opti I bought 3 months of Wellbiome today using the 20 per cent off code.its of note that all the claims are related to the magnesium within and not the microbiome.its the microbiome that attracts me and I will report any subjective benefits.
The Hull trial is interesting and a bit left field but lets see how it goes.
Company &
Holding Avg Cost
Per Share Book Cost Latest Price Valuation Profit / Loss
OPTIBIOTIX HEALTH ORD GBP0.02 (OPTI)
27637 25.3272p £6,999.68 *37.75p £10,432.97 £3,433.29 49.05%
Not bad for a share I said was going down the pan although I wish I still had my 35K sitting there.
Surely It won't all go wrong again!